002173 创新医疗
2025/06 - 中期2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-0.642-5.153-1.817-3.783-5.021
总资产报酬率 ROA (%)-0.521-4.189-1.484-3.007-3.963
投入资产回报率 ROIC (%)-0.589-4.771-1.691-3.430-4.500

边际利润分析
销售毛利率 (%)12.0567.80511.4464.3106.736
营业利润率 (%)-2.140-7.394-3.183-11.075-7.923
息税前利润/营业总收入 (%)-2.543-12.666-5.917-12.053-15.341
净利润/营业总收入 (%)-2.787-11.518-4.256-10.370-14.526

收益指标分析
经营活动净收益/利润总额(%)119.82659.32165.472112.33472.402
价值变动净收益/利润总额(%)-1.316-1.9685.257-4.524-15.363
营业外收支净额/利润总额(%)18.68840.04726.670-4.41045.315

偿债能力分析
流动比率 (X)1.9941.8642.2532.3942.717
速动比率 (X)1.8901.7342.1242.2412.593
资产负债率 (%)18.02819.36717.98818.57722.216
带息债务/全部投入资本 (%)3.4043.2062.3751.8231.377
股东权益/带息债务 (%)2,696.6152,861.6303,931.3775,086.9346,445.184
股东权益/负债合计 (%)454.406416.119455.706438.085349.924
利息保障倍数 (X)-28.33837.9683.7538.33617.972

营运能力分析
应收账款周转天数 (天)44.62050.07834.49934.21939.520
存货周转天数 (天)18.28820.05322.97624.46321.029